The US Patent and Trademark Office convinced a Virginia federal judge it rightfully denied La Jolla Pharma LLC’s applications for a method of treating distributive shock.
La Jolla’s two applications concern inventions that are unpatentable due to being anticipated or obvious, according to an opinion issued Wednesday in the US District Court for the Eastern District of Virginia. Judge Leonie Brinkema ruled that the applications “sweep much more broadly than these alleged innovations.”
Distributive shock is a condition in which a person experiences low blood pressure and an insufficient blood distribution that can impact organ function.
The pharmaceutical company argued ...